Log In

Axcella Therapeutics (AXLA)

Down But Not Out After Restructuring

‌
Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
December 16, 2022
Report ID: 25472
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

‌
Axcella Therapeutics
Axcella Therapeutics
Healthcare
Biotechnology
Ticker
AXLA
Current Price
$0.46 -7.63%
Market Cap
$16.8M
Price Target
Refer to Report
Volume
59.9K
52wk Range
$0.1621 - $2.89
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
2/17/2023
‌
Regulatory Pathway Clarified for AXA1125
Regulatory Pathway Clarified for AXA1125 (AXLA)
3 min read
2/16/2023
‌
Phase 2b/3 Trial Receives Clearance To Move Forward
Phase 2b/3 Trial Receives Clearance To Move Forward (AXLA)
0 min read
1/25/2023
‌
Long COVID Phase 2b/3 Trial Changes The AXA1125 Outlook
Long COVID Phase 2b/3 Trial Changes The AXA1125 Outlook (AXLA)
2 min read
12/16/2022
‌
Down But Not Out After Restructuring
Down But Not Out After Restructuring (AXLA)
0 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In